Stockscreener 앱 받기
1.32
2.21%
-0.04
전일 마감가:
$1.36
열려 있는:
$1.34
하루 거래량:
976
Relative Volume:
0.00
시가총액:
$10.36M
수익:
$598.00K
순이익/손실:
$-44.93M
주가수익비율:
-0.1588
EPS:
-8.31
순현금흐름:
$-17.32M
1주 성능:
+2.31%
1개월 성능:
-12.50%
6개월 성능:
-41.92%
1년 성능:
-69.32%
1일 변동 폭
$1.32
$1.34
1주일 범위
$1.22
$1.50
52주 변동 폭
$1.09
$14.40
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
명칭
Ernexa Therapeutics Inc
전화
(617) 798-6700
주소
1035 CAMBRIDGE STREET, CAMBRIDGE
ERNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.32 | 10.67M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.88 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.41 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
844.13 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.26 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.27 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ernexa Therapeutics Inc 주식(ERNA)의 최신 뉴스
Ernexa Therapeutics stock falls after ASH meeting presentation - Investing.com
Ernexa reports promising preclinical data for cancer cell therapy By Investing.com - Investing.com Australia
Ernexa Therapeutics stock falls after ASH meeting presentation By Investing.com - Investing.com Canada
Ernexa Therapeutics Presents New Preclinical Data on ERNA-101 at ASH Annual Meeting Highlighting Innovative Cell Therapy Potential to Combat Cancer - Quiver Quantitative
Ernexa reports promising preclinical data for cancer cell therapy - Investing.com
Ernexa Therapeutics Presents New Preclinical Data at - GlobeNewswire
Ernexa Therapeutics (ERNA) Stock Analysis Report | Financials & Insights - Benzinga
With Ernexa Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Can Ernexa Therapeutics Stock Recover If Markets Fall? - Trefis
Ernexa Therapeutics Inc. (ERNA) 5.2% in After-hours: Strong Presentation Initiative - Stocks Telegraph
Ernexa Therapeutics announces oral presentation at the 67th American Society of Hematology - marketscreener.com
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting - GlobeNewswire
Can Ernexa Therapeutics Inc. stock hit analyst price targetsWeekly Stock Recap & AI Powered Trade Plan Recommendations - Newser
How Ernexa Therapeutics Inc. stock compares to market leadersTrade Analysis Summary & Verified Stock Trade Ideas - Newser
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG - markets.businessinsider.com
Ernexa Therapeutics appoints oncologist Dr. Winer to advisory board By Investing.com - Investing.com Australia
Ernexa Therapeutics appoints oncologist Dr. Winer to advisory board - Investing.com
Ernexa Therapeutics Appoints Dr. Ira S. Winer to Scientific and Medical Advisory Board - Quiver Quantitative
Profit Review: How Ernexa Therapeutics Inc. stock compares to industry benchmarks2025 Historical Comparison & Fast Moving Trade Plans - BỘ NỘI VỤ
Contrasting Ernexa Therapeutics (NASDAQ:ERNA) & KalVista Pharmaceuticals (NASDAQ:KALV) - Defense World
How Ernexa Therapeutics Inc. stock reacts to oil pricesJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
How to monitor Ernexa Therapeutics Inc. with trend dashboardsTrade Entry Summary & Low Risk Entry Point Tips - newser.com
Ernexa Therapeutics Inc. stock chart pattern explained2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
Sector ETF performance correlation with Ernexa Therapeutics Inc.Gap Down & Free AI Powered Buy and Sell Recommendations - newser.com
Is it too late to sell Ernexa Therapeutics Inc.Earnings Risk Report & AI Enhanced Trading Alerts - newser.com
Will Ernexa Therapeutics Inc. bounce back from current supportGold Moves & Real-Time Stock Entry Alerts - newser.com
Why Ernexa Therapeutics Inc. stock could see breakout soonTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Analyzing drawdowns of Ernexa Therapeutics Inc. with statistical toolsGap Down & Long-Term Safe Investment Plans - newser.com
Will Ernexa Therapeutics Inc. stock benefit from automationEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Should I hold or sell Ernexa Therapeutics Inc. stock in 2025Forecast Cut & Free Growth Oriented Trading Recommendations - newser.com
Why Ernexa Therapeutics Inc. stock is a value investor pickJuly 2025 WrapUp & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
Ernexa Therapeutics Inc (ERNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ernexa Therapeutics Inc 주식 (ERNA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
0.56%
1.23%
자본화:
|
볼륨(24시간):